Almendarez Marcel, Gurm Hitinder S, Mariani José, Montorfano Matteo, Brilakis Emmanouil S, Mehran Roxana, Azzalini Lorenzo
Interventional Cardiology Division, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy; Interventional Cardiology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
JACC Cardiovasc Interv. 2019 Oct 14;12(19):1877-1888. doi: 10.1016/j.jcin.2019.04.055. Epub 2019 Sep 11.
Contrast-induced acute kidney injury (CI-AKI) is a potentially serious complication following coronary angiography and percutaneous coronary intervention (PCI). The incidence of CI-AKI is particularly high in patients with advanced chronic kidney disease (defined as an estimated glomerular filtration rate <30 ml/min/1.73 m). Although much effort has been dedicated to the identification and implementation of preventive measures for this complication at the pre-intervention stage, much less has been investigated on the procedural strategies and techniques to decrease the risk of CI-AKI during PCI. The mainstay of such approaches relies on the minimization of contrast volume by means of specific strategies or dedicated devices. Invasive imaging, such as intravascular ultrasound or non-contrast-based optical coherence tomography, is another pillar of any ultra-low-contrast-volume PCI protocol. Finally, an array of miscellaneous ancillary measures can be implemented to decrease the risk of CI-AKI, which includes the use of radial access, remote ischemic conditioning, and hemodynamic support in high-risk patients. The present review analyzes the technical aspects as well as the scientific evidence supporting these novel techniques, with the goal to improve the outcomes of patients at high risk for CI-AKI undergoing PCI.
造影剂诱导的急性肾损伤(CI-AKI)是冠状动脉造影和经皮冠状动脉介入治疗(PCI)后一种潜在的严重并发症。CI-AKI在晚期慢性肾脏病患者(定义为估计肾小球滤过率<30 ml/min/1.73 m²)中的发生率特别高。尽管在干预前阶段已投入大量精力来识别和实施针对该并发症的预防措施,但对于PCI期间降低CI-AKI风险的操作策略和技术的研究却少得多。此类方法的主要支柱依赖于通过特定策略或专用设备将造影剂用量降至最低。有创成像,如血管内超声或基于非造影剂的光学相干断层扫描,是任何超低造影剂用量PCI方案的另一支柱。最后,可以实施一系列其他辅助措施来降低CI-AKI的风险,包括使用桡动脉入路、远程缺血预处理以及对高危患者进行血流动力学支持。本综述分析了支持这些新技术的技术方面以及科学证据,目的是改善接受PCI的CI-AKI高危患者的治疗效果。